167 related articles for article (PubMed ID: 22154685)
1. Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer.
Evens N; Vandeputte C; Coolen C; Janssen P; Sciot R; Baekelandt V; Verbruggen AM; Debyser Z; Van Laere K; Bormans GM
Nucl Med Biol; 2012 Apr; 39(3):389-99. PubMed ID: 22154685
[TBL] [Abstract][Full Text] [Related]
2. Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
Ahmad R; Postnov A; Bormans G; Versijpt J; Vandenbulcke M; Van Laere K
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2219-2227. PubMed ID: 27488857
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
Evens N; Muccioli GG; Houbrechts N; Lambert DM; Verbruggen AM; Van Laere K; Bormans GM
Nucl Med Biol; 2009 May; 36(4):455-65. PubMed ID: 19423014
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of [
Attili B; Celen S; Ahamed M; Koole M; Haute CVD; Vanduffel W; Bormans G
Br J Pharmacol; 2019 May; 176(10):1481-1491. PubMed ID: 30588600
[TBL] [Abstract][Full Text] [Related]
7. Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects.
Ahmad R; Koole M; Evens N; Serdons K; Verbruggen A; Bormans G; Van Laere K
Mol Imaging Biol; 2013 Aug; 15(4):384-90. PubMed ID: 23508466
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor.
Slavik R; Herde AM; Bieri D; Weber M; Schibli R; Krämer SD; Ametamey SM; Mu L
Eur J Med Chem; 2015 Mar; 92():554-64. PubMed ID: 25599952
[TBL] [Abstract][Full Text] [Related]
9. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Mu L; Bieri D; Slavik R; Drandarov K; Müller A; Cermak S; Weber M; Schibli R; Krämer SD; Ametamey SM
J Neurochem; 2013 Sep; 126(5):616-24. PubMed ID: 23795580
[TBL] [Abstract][Full Text] [Related]
10. A PET brain reporter gene system based on type 2 cannabinoid receptors.
Vandeputte C; Evens N; Toelen J; Deroose CM; Bosier B; Ibrahimi A; Van der Perren A; Gijsbers R; Janssen P; Lambert DM; Verbruggen A; Debyser Z; Bormans G; Baekelandt V; Van Laere K
J Nucl Med; 2011 Jul; 52(7):1102-9. PubMed ID: 21680683
[TBL] [Abstract][Full Text] [Related]
11. The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain.
Yasuno F; Brown AK; Zoghbi SS; Krushinski JH; Chernet E; Tauscher J; Schaus JM; Phebus LA; Chesterfield AK; Felder CC; Gladding RL; Hong J; Halldin C; Pike VW; Innis RB
Neuropsychopharmacology; 2008 Jan; 33(2):259-69. PubMed ID: 17392732
[TBL] [Abstract][Full Text] [Related]
12. Labelling and biological evaluation of [(11)C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor.
Evens N; Bosier B; Lavey BJ; Kozlowski JA; Vermaelen P; Baudemprez L; Busson R; Lambert DM; Van Laere K; Verbruggen AM; Bormans GM
Nucl Med Biol; 2008 Oct; 35(7):793-800. PubMed ID: 18848664
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.
Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G
J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364
[TBL] [Abstract][Full Text] [Related]
14. PET imaging studies in rhesus monkey with the cannabinoid-1 (CB1) receptor ligand [11C]CB-119.
Hamill TG; Lin LS; Hagmann W; Liu P; Jewell J; Sanabria S; Eng W; Ryan C; Fong TM; Connolly B; Vanko A; Hargreaves R; Goulet MT; Burns HD
Mol Imaging Biol; 2009; 11(4):246-52. PubMed ID: 19130142
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
[TBL] [Abstract][Full Text] [Related]
16. What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.
Leurquin-Sterk G; Celen S; Van Laere K; Koole M; Bormans G; Langlois X; Van Hecken A; Te Riele P; Alcázar J; Verbruggen A; de Hoon J; Andrés JI; Schmidt ME
J Nucl Med; 2017 Jan; 58(1):110-116. PubMed ID: 27469358
[TBL] [Abstract][Full Text] [Related]
17. In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study.
Hosoya T; Fukumoto D; Kakiuchi T; Nishiyama S; Yamamoto S; Ohba H; Tsukada H; Ueki T; Sato K; Ouchi Y
J Neuroinflammation; 2017 Mar; 14(1):69. PubMed ID: 28356120
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject.
Liu H; Jin H; Yue X; Zhang X; Yang H; Li J; Flores H; Su Y; Perlmutter JS; Tu Z
Neuroimage; 2015 Nov; 121():253-62. PubMed ID: 26216275
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the cannabinoid CB₁ receptor PET ligand ortholog, [³H]MePPEP.
Suter TM; Chesterfield AK; Bao C; Schaus JM; Krushinski JH; Statnick MA; Felder CC
Eur J Pharmacol; 2010 Dec; 649(1-3):44-50. PubMed ID: 20851117
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary studies of
Zhang X; Zhang Y; Chen Z; Shao T; Van R; Kumata K; Deng X; Fu H; Yamasaki T; Rong J; Hu K; Hatori A; Xie L; Yu Q; Ye W; Xu H; Sheffler DJ; Cosford NDP; Shao Y; Tang P; Wang L; Zhang MR; Liang SH
Theranostics; 2020; 10(24):11178-11196. PubMed ID: 33042277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
